Brief: Superbac Plans To List On Nasdaq Through Business Combination With Xpac
25/04/2022 14:50
April 25 (Reuters) - XPAC Acquisition Corp XPAX.O :
* SUPERBAC, A LEADING BIOTECH COMPANY IN BRAZIL, PLANS TO
LIST ON
NASDAQ THROUGH A BUSINESS COMBINATION WITH XPAC
* XPAC ACQUISITION CORP - COMBINED COMPANY IS EXPECTED TO
HAVE A
PRO FORMA IMPLIED EQUITY VALUE POST-MONEY OF UP TO APPROXIMATELY
US$500 MILLION
* XPAC ACQUISITION CORP - SUPERBAC WILL BECOME INDIRECT UNIT
OF
PUBCO, WITH PUBCO INDIRECTLY OWNING NO LESS THAN 95% OF EQUITY
INTERESTS IN SUPERBAC
* XPAC ACQUISITION CORP - UPON COMPLETION, EXISTING
SHAREHOLDERS
OF SUPERBAC ARE EXPECTED TO OWN ABOUT 45% OF TOTAL SHARE CAPITAL
OF PUBCO
* XPAC ACQUISITION CORP - UPON COMPLETION XPAC’S EXISTING
PUBLIC
SHAREHOLDERS ARE EXPECTED TO OWN ABOUT 44% OF THE TOTAL SHARE
CAPITAL OF PUBCO
Source text: (https://bit.ly/36Nb5Ry)
Further company coverage: XPAX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zalatoris II Acquisition
See all newsBrief: Zalatoris II Acquisition, Former Board Appointed Llewellyn Farquharson As Chief Executive Officer And Director Of Company
Brief: Zalatoris Ii Acquisition Corp On March 28, Received Notice From Nasdaq Stating That Co Has Not Regained Compliance With Rule Within Compliance Period
Brief: Eco Modular To Go Public Through Merger With Zalatoris Ii Acquisition Corp
Brief: Zalatoris II Acquisition Corp - To Extend Period Of Time It Has To Consummate Its Initial Business Combination By One Month To November 3, 2023
Brief: Xpac Acquisition Corp - On May 2 Superbac Biotechnology Solutions S.A Informed Co That It Had Decided To Terminate Business Combination Agreement